Consultancy services

Evidence reviews

• Systematic literature reviews
• Targeted, focussed and rapid reviews
• Reviews of clinical effectiveness, cost-effectiveness and health-related quality of life
• Reviews to inform cost-effectiveness model parameters
• Reviews of public health and health policy topics
• Realist and theory-led reviews to understand what works, for who and why

Patient-reported outcome measures and health utilities

• Development of patient-reported outcome measures (PROMs)
• Development of preference-based (utility) measures
• Validation of measures
• Valuation of PROMs by preference elicitation surveys (eg TTO, DCE, WTP)
• Measures for carers and social care users
• Using utility measures in cost-effectiveness models
• Mapping PROMs to generic utility measures using advanced methods
• Reviewing health state utility values

Evidence synthesis

• Meta-analysis
• Bayesian network meta-analysis and indirect treatment comparisons
• Individual patient data (IPD) analyses
• Realist synthesis

Statistical analysis

• Survival modelling and extrapolation
• Analysis of treatment switching
• Analysis of real world data and observational studies

Health economics and decision modelling

• Cost-effectiveness modelling
• Critique and validation of existing models
• Country-specific model adaptations
• Early conceptual modelling
• Social return on investment and social value

Evaluation services

• A wide range of evaluation, monitoring and learning approaches, at any stage including evaluative assessments, formative, process, developmental and summative evaluation
• Evaluation of innovations, services and programmes for health and social care, third sector, large multinational companies and SMEs
• Programme theory development, impact planning, understanding behaviour change and describing and designing service delivery models
• Impact of services on health and wellbeing
• Evaluation of service and pathway redesign and policy influence, from small projects to whole system change
• Mixed methods approaches with equally strong emphasis on quantitative and qualitative work
• Real-world evaluation: innovative solutions for constraints of time, resources and data
• Specialists in workforce change and digital health technology
• External oversight of your evaluation findings and reports
• Evaluation training

Strategy and thought leadership

• Portfolio planning
• Early product value assessment
• Implementation planning
• Methodological and strategic advice
• Organising and attending or chairing advisory boards (clinical and economic)
• Review, critique and development of HEOR evidence generation plans (eg clinical trial design and outcomes assessment or instrument selection, payer evidence planning)
• Review and critique of existing economic models and HTA evidence materials
• Mock HTA appraisal meetings
• Critical review of HTA submissions
• Preparation for formal HTA scientific advice
• Integrated strategic support

Contact

For more information about what we offer, contact us.